New Drug Resmetirom for Non-Alcholic SteatoHepatitis | Diabetic Mediterranean Diet
Stages of liver damage. Healthy, fatty, liver fibrosis and cirrhosis. Vector illustration DiabetesDaily informed me of a new drug available for treatment of a liver disease that affects "up to 20% of people with diabetes. The disease is MASH: metabolic dysfunction-associated steatohepatitis, something else I'd never heard of. (Shouldn't the acronym be MDASH?) The drug…